A new JAMA study suggests ADHD medication may lower overall mortality risk. This large Swedish study followed nearly 150,000 ADHD patients. Those taking medication consistently saw a reduced risk of death from all and unnatural causes.
Read the full article here: https://jamanetwork.com/journals/jama/fullarticle/2816107
The national shortage of ADHD medications, including Adderall, Ritalin, Focalin, and Vyvanse, continues to impact millions of individuals and their families. In response, a member of APSARD, was recently featured in an NBC News article discussing the challenges and potential solutions.
Read the full article here: https://www.nbcnews.com/now/video/patients-and-families-frustrated-with-years-long-adhd-drug-shortage-203743301950
The storm of the Adderall shortage hasn’t subsided, leaving millions, including children with ADHD, facing continued difficulties obtaining their medication. This ongoing crisis, fueled by increased demand and manufacturing delays, forces families to scramble each month to secure the treatment they need.
Read more from the Chicago Tribune: https://www.chicagotribune.com/2024/02/12/adhd-medication-shortage/.
